Two Sigma Investments’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Two Sigma Investments's CLBT Position: Q2 2026 in Review
Two Sigma Investments reduced its Cellebrite (CLBT) stake by 41% in Q2 2026, selling an estimated $1.25M and leaving 137,336 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2998.
Two Sigma Investments first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. The position peaked at $29.7M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Two Sigma Investments held 137,336 shares of Cellebrite worth $2.01M as of Q2 2026.
- Two Sigma Investments sold 94,586 Cellebrite shares in Q2 2026, an estimated $1.25M.
- Cellebrite made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #2998 holding.
- Two Sigma Investments first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
- Two Sigma Investments's Cellebrite position peaked at $29.7M in Q4 2024.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.